Select Publications
Journal articles
2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, 34, pp. 241 - 247, http://www.sciencedirect.com/science/article/B6WVB-4CX0S62-K6/2/82576fabf01404bdf5cb9daf484bfd5d
,2004, 'Autologous hemopoietic stem cell transplantation in severe rheumatoidarthritis: A report from the EBMT and ABMTR', Journal of Rheumatology, 31, pp. 482 - 488
,2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, 8, pp. 2765 - 2765
,2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, 104, pp. 371B - 371B
,2004, 'Rheumatoid arthritis', Best Practice and Research Clinical Haematology, 17, pp. 263 - 276, http://www.sciencedirect.com/science/article/B6WBG-4D1TPYX-7/2/eb0d083ddca8cebd0b3fee780a2cd458
,2004, 'Treatment of steroid-refractory acute graft versus host disease with low dose combination monoclonal antibody therapy: A pilot study', Blood, 104, pp. 354A - 354A
,2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, 48, pp. 1464 - 1466, http://dx.doi.org/10.1002/art.11071
,2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, 48, pp. 1463 - 1464, http://dx.doi.org/10.1002/art.10982
,2003, 'Hematopoietic stem cell transplantation for severe rheumatoid arthritis', Bone Marrow Transplantation, 32, pp. 53 - 56
,2003, 'Il-7 and therapy-induced lymphopenia in RA', Annals of the Rheumatic Diseases, 62, pp. 164 - 164
,2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, 48, pp. 1464 - 1466
,2003, 'Stem cell transplantation in rheumatic diseases', Journal of Rheumatology, 6, pp. 79 - 82
,2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, 46, pp. 2301 - 2309
,2002, 'A stem cell transplantation and gene therapy in Rheumatoid diseases', Annals of the Rheumatic Diseases
,2001, 'Stem cell transplantation for autoimmune diseases', Springer Seminars in Immunopathology, 23, pp. 193 - 213, http://dx.doi.org/10.1007/s002810100059
,2001, 'Haemopoietic stem cell transplantation', Springer Seminars in Immunopathology, pp. 193 - 213
,2001, 'Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomised comparison of urokinase versus heparin', European Journal of Cancer, pp. 2379 - 2384
,2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, 28, pp. 8 - 12
,2001, 'Stem cells in the aetiopathogenisis and therapy of rheumatic disease.', Best Practice and Research in Clinical Rheumatology, 15, pp. 711 - 726
,2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, 84, pp. 735 - 736, http://dx.doi.org/10.1055/s-0037-1614103
,1999, 'Bilateral knee osteonecrosis in a patient with thrombotic thrombocytopenic purpura', Australian and New Zealand Journal of Medicine, 29, pp. 88 - 89, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01596.x
,1998, 'Calcitriol mediated hypercalcaemia in a T cell rich B cell lymphoma [10]', Australian and New Zealand Journal of Medicine, 28, pp. 479 - 480, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02091.x
,1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, 30, pp. 316 - 318, http://dx.doi.org/10.1080/00313029800169526
,1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, 30, pp. 318 - 320, http://dx.doi.org/10.1080/00313029800169536
,1995, 'Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.', The cancer journal from Scientific American, 1, pp. 252 - 260
,Conference Papers
2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Rate of Menstruation History Taking and Counselling Before, During and After Anticancer Treatments', in AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, WILEY, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000918712800028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 20 - 20, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899138300042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Autologous Haematopoietic Stem Cell Transplantation for Systemic Sclerosis Results in Sustained Changes in Immunoregulatory T and NK Cells', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1113 - 1114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-127796
,2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-125154
,2019, 'Preliminary Minimal Residual Disease Analysis of the Australasian Leukaemia & Lymphoma Group (ALLG) ALL8 Study of Front-Line Blinatumomab with Chemotherapy in Adults with Ph Negative B-Cell Acute Lymphoblastic Leukaemia', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-132048
,2019, 'Immune reconstitution following autologous haematopoietic stem cell transplantation for multiple sclerosis is driven by sustained thymic reactivation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GERMANY, Frankfurt, pp. 32 - 33, presented at 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), GERMANY, Frankfurt, 24 March 2019 - 27 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487707800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702802073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Efficacy of Etanercept in patients with steroid refractory acute graft versus host disease', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 412 - 413, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702804051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Autologous haematopoietic stem cell transplantation (aHSCT) in multiple sclerosis (MS) a phase II trial at St Vincent's Hospital, Sydney', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP6 - NP6, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Autologous stem cell transplantation (ASCT) in relapse remitting (RR-MS) and secondary progressive multiple sclerosis (SP-MS): an Australian-based prospective phase II trial', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, FRANCE, Marseille, pp. S43 - S44, presented at 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), FRANCE, Marseille, 26 March 2017 - 29 March 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424355300048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), CA, San Diego, 03 December 2016 - 06 December 2016, http://dx.doi.org/10.1182/blood.V128.22.338.338
,2016, 'The experience of survival following Blood and Marrow Transplant in NSW, Australia', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, SPAIN, Valencia, pp. S224 - S225, presented at 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, SPAIN, Valencia, 03 April 2016 - 06 April 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373357600393&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'FEAR OF CANCER RECURRENCE POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR MALIGNANT DISEASE: ADAPTING TO THE 'NEW NORMAL'', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 110 - 111, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'HEMATOPOIETIC STEM CELL TRANSPLANTATION, SURVIVORSHIP AND QUALITY OF LIFE: IS IT A SMALL WORLD AFTER ALL?', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 113 - 113, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'THE EXPERIENCE OF SURVIVAL FOLLOWING BLOOD AND MARROW TRANSPLANT IN NSW, AUSTRALIA', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 122 - 122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Does Ex Vivo CD34+Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at 56th Annual Meeting of the American-Society-of-Hematology, CA, San Francisco, 06 December 2014 - 09 December 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349243502176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Defining Prognostic Markers in Heart and Lung Transplant Recipients with PTLD', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S84 - S84, presented at 34th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CA, San Diego, 10 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/j.healun.2014.01.260
,2014, 'The Australian Experience with Relapsed Acute Myeloid Leukaemia Post Allogeneic Haematopoietic Stem Cell Transplantation Yields a Simple Prognostic Index for Survival after Relapse', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, TX, Grapevine, pp. S38 - S39, presented at BMT Tandem Meetings, TX, Grapevine, 26 February 2014 - 02 March 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331155400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'GENE ARRAY ANALYSIS OF HUMAN HEMATOPOIETIC STEM CELLS REVEALS ASSOCIATION BETWEEN AGE, ALTERED SIGNALING AND LOSS OF LYMPHOCYTE POTENTIAL', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S33 - S33, presented at 42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), AUSTRIA, Vienna, 22 August 2013 - 25 August 2013, http://dx.doi.org/10.1016/j.exphem.2013.05.130
,2013, 'Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CANADA, Montreal, pp. S254 - S254, presented at 33rd Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CANADA, Montreal, 24 April 2013 - 27 April 2013, http://dx.doi.org/10.1016/j.healun.2013.01.657
,2013, 'Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, pp. S184 - S184, presented at BMT Tandem Meetings, UT, Salt Lake City, 13 February 2013 - 17 February 2013, http://dx.doi.org/10.1016/j.bbmt.2012.11.179
,2012, 'Rituximab and total nodal irradiation in the treatment of extensive chronic graft-versus-host disease: interim results of a phase 2 study', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, SWITZERLAND, Geneva, pp. S409 - S410, presented at 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), SWITZERLAND, Geneva, 01 April 2012 - 04 April 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302749201664&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, pp. 1700 - 1700, presented at 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, CA, San Diego, 10 December 2011 - 13 December 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299597106142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,